New FDA tool aims to inform cancer care, but experts warn of data gaps

New FDA tool aims to inform cancer care, but experts warn of data gaps

A new FDA tool aims to inform cancer care, but experts say it has a glaring gap

By THERESA GAFFNEY

ADOBE

The platform gives cancer patients and physicians a way to comb through data on the experiences of clinical trial participants.

READ MORE